Schönfeld, Barbara V.
Westedt, Ulrich
Keller, Benjamin-Luca
Wagner, Karl G.
Funding for this research was provided by:
Rheinische Friedrich-Wilhelms-Universität Bonn
Article History
Received: 14 February 2022
Accepted: 18 April 2022
First Online: 9 May 2022
Declarations
:
: Barbara V. Schönfeld, Benjamin-Luca Keller, and Ulrich Westedt are employees of AbbVie and may own AbbVie stock. Barbara V. Schönfeld is a PhD student, and Karl G. Wagner is a professor at the University of Bonn. They have no additional conflicts of interest to report.